Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 10 |
NetGPI | no | yes: 0, no: 10 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005634 | nucleus | 5 | 1 |
GO:0043226 | organelle | 2 | 1 |
GO:0043227 | membrane-bounded organelle | 3 | 1 |
GO:0043229 | intracellular organelle | 3 | 1 |
GO:0043231 | intracellular membrane-bounded organelle | 4 | 1 |
GO:0110165 | cellular anatomical entity | 1 | 1 |
Related structures:
AlphaFold database: A4I0N6
Term | Name | Level | Count |
---|---|---|---|
GO:0006139 | nucleobase-containing compound metabolic process | 3 | 1 |
GO:0006396 | RNA processing | 6 | 1 |
GO:0006399 | tRNA metabolic process | 7 | 1 |
GO:0006400 | tRNA modification | 6 | 1 |
GO:0006725 | cellular aromatic compound metabolic process | 3 | 1 |
GO:0006807 | nitrogen compound metabolic process | 2 | 1 |
GO:0008033 | tRNA processing | 8 | 1 |
GO:0008152 | metabolic process | 1 | 1 |
GO:0009451 | RNA modification | 5 | 1 |
GO:0009987 | cellular process | 1 | 1 |
GO:0016070 | RNA metabolic process | 5 | 1 |
GO:0034470 | ncRNA processing | 7 | 1 |
GO:0034641 | cellular nitrogen compound metabolic process | 3 | 1 |
GO:0034660 | ncRNA metabolic process | 6 | 1 |
GO:0043170 | macromolecule metabolic process | 3 | 1 |
GO:0043412 | macromolecule modification | 4 | 1 |
GO:0044237 | cellular metabolic process | 2 | 1 |
GO:0044238 | primary metabolic process | 2 | 1 |
GO:0046483 | heterocycle metabolic process | 3 | 1 |
GO:0061504 | cyclic threonylcarbamoyladenosine biosynthetic process | 7 | 1 |
GO:0071704 | organic substance metabolic process | 2 | 1 |
GO:0090304 | nucleic acid metabolic process | 4 | 1 |
GO:1901360 | organic cyclic compound metabolic process | 3 | 1 |
Term | Name | Level | Count |
---|---|---|---|
GO:0003824 | catalytic activity | 1 | 11 |
GO:0008641 | ubiquitin-like modifier activating enzyme activity | 2 | 11 |
GO:0016874 | ligase activity | 2 | 11 |
GO:0016877 | ligase activity, forming carbon-sulfur bonds | 3 | 11 |
GO:0140096 | catalytic activity, acting on a protein | 2 | 11 |
GO:0140657 | ATP-dependent activity | 1 | 11 |
GO:0016829 | lyase activity | 2 | 1 |
GO:0016835 | carbon-oxygen lyase activity | 3 | 1 |
GO:0016836 | hydro-lyase activity | 4 | 1 |
GO:0061503 | tRNA threonylcarbamoyladenosine dehydratase | 5 | 1 |
GO:0140098 | catalytic activity, acting on RNA | 3 | 1 |
GO:0140101 | catalytic activity, acting on a tRNA | 4 | 1 |
GO:0140640 | catalytic activity, acting on a nucleic acid | 2 | 1 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 122 | 126 | PF00656 | 0.262 |
CLV_C14_Caspase3-7 | 167 | 171 | PF00656 | 0.349 |
CLV_NRD_NRD_1 | 183 | 185 | PF00675 | 0.393 |
CLV_NRD_NRD_1 | 251 | 253 | PF00675 | 0.504 |
CLV_NRD_NRD_1 | 256 | 258 | PF00675 | 0.508 |
CLV_NRD_NRD_1 | 267 | 269 | PF00675 | 0.415 |
CLV_NRD_NRD_1 | 85 | 87 | PF00675 | 0.322 |
CLV_PCSK_FUR_1 | 252 | 256 | PF00082 | 0.549 |
CLV_PCSK_KEX2_1 | 183 | 185 | PF00082 | 0.273 |
CLV_PCSK_KEX2_1 | 251 | 253 | PF00082 | 0.455 |
CLV_PCSK_KEX2_1 | 254 | 256 | PF00082 | 0.459 |
CLV_PCSK_KEX2_1 | 261 | 263 | PF00082 | 0.477 |
CLV_PCSK_KEX2_1 | 266 | 268 | PF00082 | 0.434 |
CLV_PCSK_KEX2_1 | 85 | 87 | PF00082 | 0.297 |
CLV_PCSK_PC1ET2_1 | 254 | 256 | PF00082 | 0.493 |
CLV_PCSK_PC1ET2_1 | 261 | 263 | PF00082 | 0.515 |
CLV_PCSK_PC1ET2_1 | 266 | 268 | PF00082 | 0.475 |
CLV_PCSK_PC7_1 | 257 | 263 | PF00082 | 0.581 |
CLV_PCSK_SKI1_1 | 130 | 134 | PF00082 | 0.278 |
CLV_PCSK_SKI1_1 | 187 | 191 | PF00082 | 0.501 |
CLV_PCSK_SKI1_1 | 261 | 265 | PF00082 | 0.538 |
DEG_Nend_Nbox_1 | 1 | 3 | PF02207 | 0.483 |
DEG_SPOP_SBC_1 | 58 | 62 | PF00917 | 0.340 |
DOC_MAPK_gen_1 | 183 | 191 | PF00069 | 0.333 |
DOC_MAPK_gen_1 | 64 | 71 | PF00069 | 0.287 |
DOC_USP7_MATH_1 | 144 | 148 | PF00917 | 0.340 |
DOC_USP7_MATH_1 | 173 | 177 | PF00917 | 0.215 |
DOC_USP7_MATH_1 | 70 | 74 | PF00917 | 0.262 |
DOC_USP7_UBL2_3 | 254 | 258 | PF12436 | 0.449 |
DOC_USP7_UBL2_3 | 261 | 265 | PF12436 | 0.482 |
DOC_WW_Pin1_4 | 268 | 273 | PF00397 | 0.584 |
LIG_Actin_WH2_2 | 222 | 239 | PF00022 | 0.403 |
LIG_Clathr_ClatBox_1 | 68 | 72 | PF01394 | 0.278 |
LIG_FHA_1 | 126 | 132 | PF00498 | 0.386 |
LIG_FHA_1 | 30 | 36 | PF00498 | 0.393 |
LIG_FHA_1 | 8 | 14 | PF00498 | 0.373 |
LIG_FHA_2 | 102 | 108 | PF00498 | 0.304 |
LIG_FHA_2 | 165 | 171 | PF00498 | 0.361 |
LIG_FHA_2 | 50 | 56 | PF00498 | 0.268 |
LIG_LIR_Apic_2 | 219 | 225 | PF02991 | 0.298 |
LIG_LIR_Nem_3 | 55 | 59 | PF02991 | 0.402 |
LIG_MYND_1 | 200 | 204 | PF01753 | 0.502 |
LIG_RPA_C_Fungi | 172 | 184 | PF08784 | 0.235 |
LIG_RPA_C_Insects | 172 | 187 | PF08784 | 0.242 |
LIG_SH2_CRK | 117 | 121 | PF00017 | 0.218 |
LIG_SH2_CRK | 222 | 226 | PF00017 | 0.278 |
LIG_SH2_CRK | 56 | 60 | PF00017 | 0.396 |
LIG_SH2_NCK_1 | 56 | 60 | PF00017 | 0.396 |
LIG_SH2_STAP1 | 117 | 121 | PF00017 | 0.262 |
LIG_SH3_2 | 201 | 206 | PF14604 | 0.479 |
LIG_SH3_3 | 198 | 204 | PF00018 | 0.464 |
LIG_Sin3_3 | 232 | 239 | PF02671 | 0.376 |
LIG_SUMO_SIM_anti_2 | 188 | 196 | PF11976 | 0.461 |
LIG_SUMO_SIM_anti_2 | 50 | 55 | PF11976 | 0.396 |
LIG_SUMO_SIM_par_1 | 157 | 163 | PF11976 | 0.424 |
LIG_SUMO_SIM_par_1 | 67 | 74 | PF11976 | 0.278 |
LIG_SUMO_SIM_par_1 | 95 | 100 | PF11976 | 0.363 |
LIG_TYR_ITIM | 54 | 59 | PF00017 | 0.386 |
MOD_CK1_1 | 157 | 163 | PF00069 | 0.393 |
MOD_CK2_1 | 75 | 81 | PF00069 | 0.340 |
MOD_GlcNHglycan | 232 | 235 | PF01048 | 0.352 |
MOD_GlcNHglycan | 3 | 6 | PF01048 | 0.496 |
MOD_GSK3_1 | 18 | 25 | PF00069 | 0.386 |
MOD_GSK3_1 | 187 | 194 | PF00069 | 0.401 |
MOD_GSK3_1 | 212 | 219 | PF00069 | 0.578 |
MOD_GSK3_1 | 268 | 275 | PF00069 | 0.644 |
MOD_GSK3_1 | 71 | 78 | PF00069 | 0.278 |
MOD_N-GLC_1 | 216 | 221 | PF02516 | 0.397 |
MOD_NEK2_1 | 1 | 6 | PF00069 | 0.517 |
MOD_NEK2_1 | 216 | 221 | PF00069 | 0.459 |
MOD_NEK2_1 | 22 | 27 | PF00069 | 0.398 |
MOD_NEK2_1 | 230 | 235 | PF00069 | 0.238 |
MOD_NEK2_1 | 29 | 34 | PF00069 | 0.396 |
MOD_NEK2_1 | 71 | 76 | PF00069 | 0.262 |
MOD_OFUCOSY | 123 | 129 | PF10250 | 0.386 |
MOD_PIKK_1 | 7 | 13 | PF00454 | 0.368 |
MOD_PKA_2 | 173 | 179 | PF00069 | 0.365 |
MOD_Plk_1 | 187 | 193 | PF00069 | 0.480 |
MOD_Plk_1 | 212 | 218 | PF00069 | 0.591 |
MOD_Plk_1 | 7 | 13 | PF00069 | 0.348 |
MOD_Plk_1 | 71 | 77 | PF00069 | 0.262 |
MOD_Plk_4 | 154 | 160 | PF00069 | 0.381 |
MOD_ProDKin_1 | 268 | 274 | PF00069 | 0.588 |
MOD_SUMO_rev_2 | 256 | 263 | PF00179 | 0.589 |
TRG_ENDOCYTIC_2 | 117 | 120 | PF00928 | 0.262 |
TRG_ENDOCYTIC_2 | 56 | 59 | PF00928 | 0.396 |
TRG_ER_diArg_1 | 114 | 117 | PF00400 | 0.262 |
TRG_ER_diArg_1 | 183 | 185 | PF00400 | 0.306 |
TRG_ER_diArg_1 | 85 | 88 | PF00400 | 0.322 |
TRG_NLS_Bipartite_1 | 251 | 269 | PF00514 | 0.548 |
TRG_NLS_MonoCore_2 | 264 | 269 | PF00514 | 0.603 |
TRG_NLS_MonoExtC_3 | 264 | 269 | PF00514 | 0.553 |
TRG_NLS_MonoExtN_4 | 262 | 269 | PF00514 | 0.540 |
TRG_Pf-PMV_PEXEL_1 | 177 | 181 | PF00026 | 0.231 |
TRG_Pf-PMV_PEXEL_1 | 85 | 89 | PF00026 | 0.322 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1I6Q3 | Leptomonas seymouri | 82% | 100% |
A0A0S4KJM6 | Bodo saltans | 67% | 84% |
A0A1X0NJ23 | Trypanosomatidae | 65% | 95% |
A0A3Q8ICX5 | Leishmania donovani | 96% | 100% |
A0A422P452 | Trypanosoma rangeli | 67% | 100% |
D0A715 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 67% | 99% |
E9AWN6 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 89% | 100% |
O32037 | Bacillus subtilis (strain 168) | 33% | 100% |
Q46927 | Escherichia coli (strain K12) | 39% | 100% |
Q4QAT5 | Leishmania major | 91% | 100% |
Q57097 | Haemophilus influenzae (strain ATCC 51907 / DSM 11121 / KW20 / Rd) | 34% | 100% |
V5BVX4 | Trypanosoma cruzi | 67% | 84% |